Recently, we used SAA-targeted antisense oligonucleotide (ASOSAA) on a high-fat diet-induced obesity model and identified SAA as an additional trigger driving endotoxemia, weight gain and insulin signaling impairment [4]. Here, SAA1 is linked to obesity disorder.